Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Davis

Showing results (361-370 of 404) with videos related to

Pageof 41
Sort By:
Cancer|November 5, 1997
Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumorsF G Barker, S M Chang, S L Huhn, et al.
The Journal of Clinical Investigation|December 1, 1995
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primateC P Genain, M H Nguyen, N L Letvin, et al.
Cancer Research|May 19, 2001
Ethnicity delineates different genetic pathways in malignant gliomaP Chen, K Aldape, J K Wiencke, et al.
Cancer Treatment Reports|June 1, 1986
Northern California Oncology Group protocol 6G91: response to treatment with radiation therapy and seven-drug chemotherapy in patients with glioblastoma multiformeV A Levin, W M Wara, R L Davis, et al.
Clinical Pharmacology and Therapeutics|January 21, 2011
The emerging role of electronic medical records in pharmacogenomicsR A Wilke, H Xu, J C Denny, et al.
Molecular and Cellular Biology|June 1, 1990
Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesteraseG P Livi, P Kmetz, M M McHale, et al.
Neurosurgery|April 1, 1985
Radiation brain damage induced by interstitial 125I sources: a canine model evaluated by quantitative computed tomographyJ R Fike, C E Cann, T L Phillips, et al.
Cancer Research|November 1, 1986
Establishment and characterization of a cell line from a human gliosarcomaJ T Rutka, J R Giblin, H K Høifødt, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1991
Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II studyT L Phillips, V A Levin, D K Ahn, et al.
Statistics in Medicine|March 1, 1993
Monitoring of clinical trials and interim analyses from a drug sponsor's point of viewG W Williams, R L Davis, A J Getson, et al.
Pageof 41

Showing results (361-370 of 404) with videos related to

Sort By:
Pageof 41
Cancer|November 5, 1997
Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumorsF G Barker, S M Chang, S L Huhn, et al.
The Journal of Clinical Investigation|December 1, 1995
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primateC P Genain, M H Nguyen, N L Letvin, et al.
Cancer Research|May 19, 2001
Ethnicity delineates different genetic pathways in malignant gliomaP Chen, K Aldape, J K Wiencke, et al.
Cancer Treatment Reports|June 1, 1986
Northern California Oncology Group protocol 6G91: response to treatment with radiation therapy and seven-drug chemotherapy in patients with glioblastoma multiformeV A Levin, W M Wara, R L Davis, et al.
Clinical Pharmacology and Therapeutics|January 21, 2011
The emerging role of electronic medical records in pharmacogenomicsR A Wilke, H Xu, J C Denny, et al.
Molecular and Cellular Biology|June 1, 1990
Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesteraseG P Livi, P Kmetz, M M McHale, et al.
Neurosurgery|April 1, 1985
Radiation brain damage induced by interstitial 125I sources: a canine model evaluated by quantitative computed tomographyJ R Fike, C E Cann, T L Phillips, et al.
Cancer Research|November 1, 1986
Establishment and characterization of a cell line from a human gliosarcomaJ T Rutka, J R Giblin, H K Høifødt, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1991
Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II studyT L Phillips, V A Levin, D K Ahn, et al.
Statistics in Medicine|March 1, 1993
Monitoring of clinical trials and interim analyses from a drug sponsor's point of viewG W Williams, R L Davis, A J Getson, et al.
Pageof 41